Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1.

Lemaire R, Burwell T, Sun H, Delaney T, Bakken J, Cheng L, Rebelatto MC, Czapiga M, de-Mendez I, Coyle AJ, Herbst R, Lafyatis R, Connor J.

Arthritis Rheumatol. 2016 Feb;68(2):473-83. doi: 10.1002/art.39443.

2.

Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.

Corallo C, Paulesu L, Cutolo M, Ietta F, Carotenuto C, Mannelli C, Romagnoli R, Nuti R, Giordano N.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S98-105. Epub 2015 May 25.

PMID:
26005773
3.

Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis.

Kudo H, Jinnin M, Asano Y, Trojanowska M, Nakayama W, Inoue K, Honda N, Kajihara I, Makino K, Fukushima S, Ihn H.

Arthritis Rheumatol. 2014 Jun;66(6):1636-47. doi: 10.1002/art.38380.

4.

Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis.

Truchetet ME, Demoures B, Eduardo Guimaraes J, Bertrand A, Laurent P, Jolivel V, Douchet I, Jacquemin C, Khoryati L, Duffau P, Lazaro E, Richez C, Seneschal J, Doutre MS, Pellegrin JL, Constans J, Schaeverbeke T, Blanco P, Contin-Bordes C; Fédération Hospitalo-Universitaire ACRONIM.

Arthritis Rheumatol. 2016 Nov;68(11):2784-2794. doi: 10.1002/art.39817. Epub 2016 Oct 9.

5.

CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.

Vorstenbosch J, Al-Ajmi H, Winocour S, Trzeciak A, Lessard L, Philip A.

Arthritis Rheum. 2013 May;65(5):1378-83. doi: 10.1002/art.37907.

6.

Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.

Manetti M, Romano E, Rosa I, Guiducci S, Bellando-Randone S, De Paulis A, Ibba-Manneschi L, Matucci-Cerinic M.

Ann Rheum Dis. 2017 May;76(5):924-934. doi: 10.1136/annrheumdis-2016-210229. Epub 2017 Jan 6.

PMID:
28062404
7.

Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis.

Desallais L, Avouac J, Fréchet M, Elhai M, Ratsimandresy R, Montes M, Mouhsine H, Do H, Zagury JF, Allanore Y.

Arthritis Res Ther. 2014 Jul 24;16(4):R157. doi: 10.1186/ar4672.

8.

Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts.

Tsou PS, Balogh B, Pinney AJ, Zakhem G, Lozier A, Amin MA, Stinson WA, Schiopu E, Khanna D, Fox DA, Koch AE.

Arthritis Res Ther. 2014;16(5):411.

9.

The plasminogen activator system in fibroblasts from systemic sclerosis.

Postiglione L, Montuori N, Riccio A, Di Spigna G, Salzano S, Rossi G, Ragno P.

Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):891-900.

PMID:
20943061
10.

Dysregulated interleukin-23 signalling contributes to the increased collagen production in scleroderma fibroblasts via balancing microRNA expression.

Nakayama W, Jinnin M, Tomizawa Y, Nakamura K, Kudo H, Inoue K, Makino K, Honda N, Kajihara I, Fukushima S, Ihn H.

Rheumatology (Oxford). 2017 Jan;56(1):145-155. doi: 10.1093/rheumatology/kew336. Epub 2016 Oct 15.

PMID:
27744356
11.

Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.

Farina G, Lemaire R, Pancari P, Bayle J, Widom RL, Lafyatis R.

Ann Rheum Dis. 2009 Mar;68(3):435-41. doi: 10.1136/ard.2007.086850. Epub 2008 Apr 13.

PMID:
18408251
12.

Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice.

Song Y, Zhu L, Li M.

Clinics (Sao Paulo). 2013 Oct;68(10):1350-7. doi: 10.6061/clinics/2013(10)10.

13.

Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.

Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A.

J Hepatol. 1999 Oct;31(4):703-11.

PMID:
10551395
14.

Differential expression of tissue kallikrein in the skin of systemic sclerosis.

Milia AF, Del Rosso A, Pacini A, Manetti M, Marrelli A, Nosi D, Giacomelli R, Matucci-Cerinic M, Ibba-Manneschi L.

Histol Histopathol. 2005 Apr;20(2):415-22. doi: 10.14670/HH-20.415.

PMID:
15736045
15.
16.

The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.

Avouac J, Palumbo-Zerr K, Ruzehaji N, Tomcik M, Zerr P, Dees C, Distler A, Beyer C, Schneider H, Distler O, Schett G, Allanore Y, Distler JH.

Arthritis Rheumatol. 2014 Nov;66(11):3140-50. doi: 10.1002/art.38819.

17.

Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis.

Huber LC, Distler JH, Moritz F, Hemmatazad H, Hauser T, Michel BA, Gay RE, Matucci-Cerinic M, Gay S, Distler O, Jüngel A.

Arthritis Rheum. 2007 Aug;56(8):2755-64.

18.

Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2).

Kanno Y, Kawashita E, Kokado A, Okada K, Ueshima S, Matsuo O, Matsuno H.

Arthritis Rheum. 2013 Feb;65(2):492-502. doi: 10.1002/art.37767. Erratum in: Arthritis Rheum. 2014 Jun;66(6):1671.

19.

Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?

Manetti M, Rosa I, Milia AF, Guiducci S, Carmeliet P, Ibba-Manneschi L, Matucci-Cerinic M.

Ann Rheum Dis. 2014 Sep;73(9):1700-9. doi: 10.1136/annrheumdis-2013-203706. Epub 2013 Jul 12.

PMID:
23852693
20.

Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.

Avouac J, Palumbo K, Tomcik M, Zerr P, Dees C, Horn A, Maurer B, Akhmetshina A, Beyer C, Sadowski A, Schneider H, Shiozawa S, Distler O, Schett G, Allanore Y, Distler JH.

Arthritis Rheum. 2012 May;64(5):1642-52. doi: 10.1002/art.33501.

Supplemental Content

Support Center